Is CLS a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Hyperscaler-driven CCS growth, with revenue (ttm) at ~$15.6B. The bear case rests on customer concentration is the headline risk: as of Q1 2026 three customers each represented at least 10% of revenue (roughly 35%, 15%, and 15%), and the top ten customers made up about ~78% of revenue, so losing or being de-prioritized by a single hyperscaler would matter a lot. Analysts covering it are spread from $375.00 to $550.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Customer concentration is the headline risk: as of Q1 2026 three customers each represented at least 10% of revenue (roughly 35%, 15%, and 15%), and the top ten customers made up about ~78% of revenue, so losing or being de-prioritized by a single hyperscaler would matter a lot. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $375.00, +23.4% from the $303.81 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Hyperscaler-driven CCS growth. The Connectivity & Cloud Solutions segment is the engine of the story, reaching roughly ~$3.24 billion in Q1 2026 and growing about ~76% year over year. The most optimistic analyst target on CLS is $550.00, +81.0% from the $303.81 price. That figure is only reachable if this thesis works close to its best case.

Customer concentration is the headline risk: as of Q1 2026 three customers each represented at least 10% of revenue (roughly 35%, 15%, and 15%), and the top ten customers made up about ~78% of revenue, so losing or being de-prioritized by a single hyperscaler would matter a lot. EMS has historically run thin margins, leaving limited cushion if pricing or volumes compress. The business is tied to AI capital spending, which is cyclical and could slow or pause after a heavy buildout phase. And the stock has re-rated to a much higher multiple than its EMS history, so it carries both competition from Jabil, Flex, Foxconn, and ODMs and the risk that high growth expectations are not met. The stock has already shown that sensitivity: it fell from a 52-week high near $474 to about $307 by October 16, 2026 during a summer pullback in AI-capex sentiment, even as quarterly results kept beating estimates. Walnut is not an investment adviser; this page describes the company and is not a recommendation. The most pessimistic published target is $375.00, +23.4% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Celestica is a Toronto-based electronics manufacturing services (EMS) and supply-chain company that designs, builds, and tests hardware for other companies.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Hyperscaler-driven CCS growth) stalling in the reported numbers rather than in the narrative, the risk above (customer concentration is the headline risk: as of Q1 2026 three customers each represented at least 10% of revenue (roughly 35%, 15%, and 15%), and the top ten customers made up about ~78% of revenue, so losing or being de-prioritized by a single hyperscaler would matter a lot) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

That depends on your goals, time horizon, and risk tolerance, and this is not advice. The bull case is rapid CCS growth, AI networking and compute content, and rising margins from hyperscaler demand. The bear case is heavy customer concentration, historically thin EMS margins, exposure to a cyclical AI-capex cycle, and a much higher valuation than its past. Weigh both against your own situation.

Celestica is an electronics manufacturing services (EMS) company that designs, builds, and tests hardware for other companies. Its CCS segment makes networking switches, servers, storage, and custom AI/ML compute hardware for data-center and communications customers, while its ATS segment serves aerospace and defense, industrial, HealthTech, and capital-equipment markets. It earns money on manufacturing volume, complexity, and higher-value design work.

No. As of October 2026 Celestica does not pay a dividend to shareholders. Any return from holding the stock would come from changes in the share price rather than dividend income. That is common for companies reinvesting heavily into a fast-growing part of their business, though it means income-focused investors get no cash payout.